Montinaro V, Hevey K, Aventaggiato L, Fadden K, Esparza A, Chen A, Finbloom D S, Rifai A
Department of Pathology, Rhode Island Hospital, Providence.
Kidney Int. 1992 Aug;42(2):341-53. doi: 10.1038/ki.1992.295.
Clinical episodes of IgA nephropathy coincide recurrently with microbial infections. Cytokines produced during such infections may play a role in the pathogenesis of IgA-associated glomerulonephritis. To test this hypothesis, we examined the influence of passively administered proinflammatory cytokines (IL-1, IFN-gamma and IL-6) on the development of glomerulonephritis in an experimental model of IgA nephropathy. Glomerular IgA immune deposits were induced in mice by administration of IgA anti-phosphorylcholine (PC) with either a PC-containing carbohydrate antigen of Pneumococcal C polysaccharide (PnC) or a protein antigen of PC-conjugated bovine serum albumin (PC-BSA). The effect of IL-1 on the IgA-PC-BSA induced glomerular changes resulted in an increase of mesangial hypercellularity that was associated with mild proteinuria and hematuria. Mice treated with IL-1 and IgA-PnC developed diffuse proliferative glomerulonephritis with proteinuria and hematuria. In contrast, IL-6 treatment with IgA-PC-BSA of IgA-PnC failed to exert any significant renal effect. The combination of IL-6 and IL-1, however, intensified the mesangial hypercellularity of the IgA-PC-BSA, and induced severe proliferative glomerulonephritis with inflammatory monocytes and neutrophils infiltrates in the IgA-PnC treated mice. These glomerular changes were also accompanied by increased proteinuria and hematuria. Similarly, the combination of IFN with IL-1 produced histologic changes and compromised renal function more than IFN or IL-1 exerted independently. These results suggest that extrarenal cytokines influence the renal response to IgA immune deposits. We also conclude that a synergy of multiple cytokines and nephritogenic antigens immobilized in glomerular IgA immune deposits may lead to rapid progression of IgA-associated glomerulonephritis.
IgA肾病的临床发作反复与微生物感染同时出现。此类感染期间产生的细胞因子可能在IgA相关性肾小球肾炎的发病机制中起作用。为验证这一假设,我们在IgA肾病的实验模型中研究了被动给予促炎细胞因子(IL-1、IFN-γ和IL-6)对肾小球肾炎发展的影响。通过给予抗磷酸胆碱(PC)的IgA与肺炎球菌C多糖(PnC)的含PC碳水化合物抗原或PC偶联牛血清白蛋白(PC-BSA)的蛋白抗原,在小鼠中诱导肾小球IgA免疫沉积物形成。IL-1对IgA-PC-BSA诱导的肾小球变化的影响导致系膜细胞增多,伴有轻度蛋白尿和血尿。用IL-1和IgA-PnC处理的小鼠发生了伴有蛋白尿和血尿的弥漫性增殖性肾小球肾炎。相比之下,用IL-6处理IgA-PC-BSA或IgA-PnC未能产生任何显著的肾脏效应。然而,IL-6和IL-1的联合使用加剧了IgA-PC-BSA的系膜细胞增多,并在IgA-PnC处理的小鼠中诱导了伴有炎性单核细胞和中性粒细胞浸润的严重增殖性肾小球肾炎。这些肾小球变化还伴有蛋白尿和血尿增加。同样,IFN与IL-1联合使用比单独使用IFN或IL-1产生的组织学变化更大,且肾功能损害更严重。这些结果表明肾外细胞因子影响肾脏对IgA免疫沉积物的反应。我们还得出结论,多种细胞因子与固定在肾小球IgA免疫沉积物中的致肾炎抗原协同作用可能导致IgA相关性肾小球肾炎快速进展。